DNA RNA and Cells

03 May 2007 Nucleonics Receives FDA Clearance to Begin Phase 1 Trial of Expressed RNAi Approach to Treating Chronic Hepatitis B Infections
02 May 2007 Cardium Advancing Excellarate to Phase 2b Clinical Study
02 May 2007 University College London, Moorfields Eye Hospital and Targeted Genetics Initiate Phase I/II Clinical Trial of Gene Therapy for Childhood Blindness
01 May 2007 Aastrom Initiates Adult Stem Cell Clinical Trial for Peripheral Arterial Disease
01 May 2007 New Report Illuminates Ampligen(R)'s Unique Mechanism of Action
28 Apr 2007 CHMP Adopts Negative Opinion on Genasense(R) Application in Melanoma
28 Apr 2007 Ark Therapeutics Grp - Regulatory Update
27 Apr 2007 Sangamo BioSciences Initiates Additional Phase 2 Clinical Trial of Novel Therapy for Moderate to Severe Diabetic Neuropathy
25 Apr 2007 Ark Therapeutics Grp - Research Update
19 Apr 2007 Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research
18 Apr 2007 Lorus Therapeutics Announces Scientific Presentations for Lead Antisense and siRNA Drug Candidates at International Cancer Conference
18 Apr 2007 Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer
18 Apr 2007 Introgen's Intravenous Nanoparticle Gene Therapy Shows Activity in Stage IV Lung Cancer Patients
18 Apr 2007 ProNAi Announces Preclinical Success for PNT2258 Therapeutic – Curative Events in Xenograft Mice for Difficult-to-Treat Non-Hodgkin's Lymphoma
17 Apr 2007 Arrowhead Subsidiaries Insert & Calando Present Data on Cyclosert Drug Delivery System at AACR Meeting
17 Apr 2007 Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of CERE-120 Demonstrating Improved Motor Function in Parkinson's Patients
17 Apr 2007 Regulatory Review Allows LCT Diabetes Clinical Program to Proceed
17 Apr 2007 Bioniche Presents Additional Data on the Anticancer Activity of MCC Against Peritoneal Carcinomatosis
14 Apr 2007 Ceregene Enrolling Patients For Phase 2 Clinical Trial Of Parkinson's Disease
12 Apr 2007 Oncolytics Biotech Inc. Proceeds to Initiate U.S. Phase II Sarcoma Clinical Trial
12 Apr 2007 Novosom AG Acquires Exclusive Option for CD40-Targeted Antisense Inhibitors From Isis Pharmaceuticals
05 Apr 2007 Genta Appeals FDA Decision on Genasense in CLL
31 Mar 2007 LCT reports major step forward for islet transplantation in diabetes patient
27 Mar 2007 Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients Presented at ACC
26 Mar 2007 Osiris Therapeutics Announces Positive Results in Groundbreaking Stem Cell Trial to Treat Heart Disease

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up